Arrhythmias & electrophysiologyCohort study

Familial risk of sinus node dysfunction indicating pacemaker implantation: a nationwide cohort study

EuropacePublished

  • Nationwide register-based cohort study

Authors' conclusion

First-degree relatives to SND patients are at increased risk of SND with risk being inversely associated with pacemaker implantation age in the index person. Mortality in first-degree relatives was comparable with the general population, although subgroup findings suggest an increased mortality among individuals with a family history of early-onset SND.

Study context

Population
Danish individuals born after 1954, followed 1982–2022
Participants
6,027,090 individuals · 180,775,041 person-years
Exposure
Relatives vs General population
Outcome
Pacemaker-treated sinus node dysfunction (SND)

Main finding

Pacemaker-treated SND

Adjusted relative risk

2.9

CI 2.4–3.6

By group

Relatives

0.79

cumulative incidence at age 68 years · %

General population

0.27%

cumulative incidence at age 68 years

Relatives vs General population
adjusted RR 2.9 (CI 2.4–3.6)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeRR (CI)
Pacemaker-treated SND, index implantation age ≤60 years (subgroup)5.5 (3.4–9.0)
Mortality, index onset ≤60 years (subgroup)1.22 (1.05–1.41)
  • Pacemaker-treated sinus node dysfunction (SND), index implantation age ≤60 years (subgroup): risk inversely proportional to implantation age in index person

Mortality

Overall mortality similar between relatives and general population

Original publication

Familial risk of sinus node dysfunction indicating pacemaker implantation: a nationwide cohort study. Europace. Published 13 November 2024. doi:10.1093/europace/euae287

Summarised from the published abstract; every number is checked against it